Andersons pediatric cardiology 1795
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.53 KB, 3 trang )
inthepostoperativemorbidityandmortality.
TransplantProc.1999;31:2503–2504.
23.GajarskiRJ,TowbinJA,BrickerJT,etal.
Intermediatefollow-upofpediatricheart
transplantrecipientswithelevatedpulmonary
vascularresistanceindex.JAmCollCardiol.
1994;23:1682–1687.
24.MaxwellBG,SheikhAY,Ajuba-IwujiCC,etal.
Pulmonaryvascularresistanceindexand
mortalityafterpediatrichearttransplant.Cardiol
Young.2015;25:1141–1147.
25.RichmondME,LawYM,DasBB,etal.Elevated
pretransplantpulmonaryvascularresistanceis
notassociatedwithmortalityinchildrenwithout
congenitalheartdisease:amulticenterstudy.J
HeartLungTransplant.2015;34:448–456.
26.WestLJ,Pollock-BarzivSM,DipchandAI,etal.
ABO-incompatiblehearttransplantationin
infants.NEnglJMed.2001;344:793–800.
27.WestL,KaramlouT,DipchandAI,etal.Impact
onoutcomesafterlistingandafter
transplantationofastrategytoacceptABO
bloodgroupincompatibledonorheartsfor
neonatesandinfants.JThoracCardiovascSurg.
2006;131:455–461.
28.DipchandAI,PollockBarZivSM,ManlhiotC,et
al.Equivalentoutcomesforpediatricheart
transplantationrecipientsABO-bloodgroup
incompatibleversusABO-compatible.AmJ
Transplant.2010;10(2):389–397.
29.UrschelS,LarsenIM,KirkR,etal.ABO
incompatiblehearttransplantationinearly
childhood:aninternationalmulticenterstudyof
clinicalexperiencesandlimits.JHeartLung
Transplant.2013;32:285–292.
30.IrvingCA,GenneryAR,CarterV,etal.ABOincompatiblecardiactransplantationinpediatric
patientswithhighisohemagglutinintiters.J
HeartLungTransplant.2015;34:1095–1102.
31.O'ConnorMJ,KeeshanBC,LinKY,etal.
Changesinthemethodologyofpre-heart
transplanthumanleukocyteantibody
assessment:ananalysisoftheunitednetworkfor
organsharingdatabase.ClinTransplant.
2015;29:842–850.
32.MahleWT,TreslerMA,EdensRE,etal.
Allosensitizationandoutcomesinpediatricheart
transplantation.JHeartLungTransplant.
2011;30:1221–1227.
33.FeingoldB,WebberSA,BryceCL,etal.
Comparisonoflistingstrategiesfor
allosensitizedhearttransplantcandidates
requiringtransplantathighurgency:adecision
modelanalysis.AmJTransplant.2015;15:427–
435.
34.TaitBD.DetectionofHLAantibodiesinorgan
transplantrecipients-triumphsandchallenges
ofthesolidphasebeadassay.FrontImmunol.
2016;7:570.
35.ThomasKA,ValenzuelaNM,ReedEF.The
perfectstorm:HLAantibodies,complement,
Fcγrsandendotheliumintransplantrejection
trends.MolMed.2015;21(5):319–329.
36.CastleberryC,RyanTD,ChinC.Transplantation
inthehighlysensitizedpediatricpatient.
Circulation.2014;129:2313–2319.
37.ChenCK,ManlhiotC,ConwayJ,etal.
Developmentandimpactofdenovoanti-HLA
antibodiesinpediatrichearttransplant
recipients.AmJTransplant.2015;15:2215–
2222.
38.IrvingCA,CarterV,GenneryAR,etal.Effectof
persistentversustransientdonor-specificHLA
antibodiesongraftoutcomesinpediatriccardiac
transplantation.JHeartLungTransplant.
2015;34:1310–1317.
39.ConwayJ,ManlhiotC,KirkR,etal.Mortality
andmorbidityafterretransplantationafter
primaryhearttransplantinchildhood:an
analysisfromtheregistryoftheinternational
societyforheartandlungtransplantation.J
